Pelthos Therapeutics (PTHS) director’s 283-share sale tied to RSU tax obligations
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Pelthos Therapeutics Inc. director Ezra M. Friedberg reported small open-market sales of common stock alongside updated indirect holdings. On June 15, 2026, he sold 59 shares at $27.9403 per share and 224 shares at $27.1245 per share in open-market transactions.
According to a footnote, these sales were made under a pre-arranged Rule 10b5-1 plan adopted on December 16, 2025 to satisfy estimated tax obligations from vesting restricted stock units. After the sales, he held 81,600 shares directly and indirectly 40,000 shares via Key Recovery Group LLC and 82,072 shares via Balmoral Financial Group LLC.
Positive
- None.
Negative
- None.
Insights
Small pre-planned sales mainly to cover taxes look routine.
The filing shows director Ezra M. Friedberg sold a total of 283 Pelthos Therapeutics common shares on June 15, 2026, at prices around the high‑$20s. The transactions are coded as open-market sales and represent a modest number of shares.
A footnote states the sales were executed under a Rule 10b5-1 plan adopted on December 16, 2025 to meet estimated tax obligations from vesting restricted stock units. Such plans are set in advance, which typically makes the timing less informative about the insider’s current view of the stock.
Following the transactions, Friedberg held 81,600 shares directly, plus 40,000 shares through Key Recovery Group LLC and 82,072 shares through Balmoral Financial Group LLC. The filing shows no derivative positions remaining, so this update mainly refreshes his equity stake and discloses routine tax-related sales.
Insider Trade Summary 10b5-1
Net Seller: 283 shares ($7,724)
Net Sell
4 txns
Insider
Friedberg Ezra M
Role
null
Sold
283 shs ($8K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 224 | $27.1245 | $6K |
| Sale | Common Stock | 59 | $27.9403 | $2K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 81,659 shares (Direct, null);
Common Stock — 82,072 shares (Indirect, By Balmoral Financial Group LLC)
Footnotes (1)
- This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer. This transaction was executed in multiple trades at prices ranging from $26.71 to $27.44. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $27.92 to $28.00. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Key Figures
Shares sold (first trade): 59 shares
Price per share (first trade): $27.9403 per share
Shares sold (second trade): 224 shares
+5 more
8 metrics
Shares sold (first trade)
59 shares
Open-market sale of common stock on June 15, 2026 at $27.9403
Price per share (first trade)
$27.9403 per share
Weighted average sale price for 59 shares of common stock
Shares sold (second trade)
224 shares
Open-market sale of common stock on June 15, 2026 at $27.1245
Price per share (second trade)
$27.1245 per share
Weighted average sale price for 224 shares of common stock
Direct holdings after sales
81,600 shares
Common stock held directly following June 15, 2026 transactions
Indirect holdings via Key Recovery Group LLC
40,000 shares
Common stock held of record by Key Recovery Group LLC
Indirect holdings via Balmoral Financial Group LLC
82,072 shares
Common stock held of record by Balmoral Financial Group LLC
Net shares sold
283 shares
Net sell volume across reported transactions per summary
Key Terms
Rule 10b5-1 plan, restricted stock units, weighted average price, beneficially own, +1 more
5 terms
Rule 10b5-1 plan regulatory
"made pursuant to a Rule 10b5-1 plan adopted December 16, 2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
restricted stock units financial
"in connection with the vesting of restricted stock units granted by the Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially own regulatory
"may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
pecuniary interest financial
"disclaims any such beneficial ownership except to the extent of his pecuniary interest therein"
FAQ
What insider transactions did Pelthos Therapeutics (PTHS) director Ezra Friedberg report?
Ezra M. Friedberg reported two small open-market sales of Pelthos Therapeutics common stock on June 15, 2026, totaling 283 shares. One trade sold 59 shares at $27.9403, and another sold 224 shares at $27.1245 per share.
Were the PTHS insider stock sales made under a Rule 10b5-1 plan?
Yes. The filing states the sales were executed under a Rule 10b5-1 trading plan adopted on December 16, 2025. The plan was established to sell shares to cover estimated tax obligations arising from vesting restricted stock units granted by Pelthos Therapeutics.
What prices did the Pelthos Therapeutics (PTHS) insider sales occur at?
The reported Pelthos Therapeutics insider sales occurred at weighted average prices of $27.9403 and $27.1245 per share. Footnotes add that the trades executed in multiple lots within ranges of $27.92–$28.00 and $26.71–$27.44, respectively.